Partner Nigel Barratt and corporate finance manager Ben Bradley advised Stockport-based Karomed on the transaction. Paul Johnson and Rachel Clarkson of law firm Ward Hadaway provided legal advice.
Karomed offers a wide range of pressure care products, including mattresses, beds, chairs and cushions, along with other complementary services to meet the needs of patients and carers in the NHS and private healthcare sectors.
The Transflo Cushion has been in the pressure care market for more than 30 years and is one of the UK’s leading high-risk gel cushions used in acute and community care settings.
Direct Healthcare, which is based in Caerphilly, is a leading manufacturer of pressure care products.
The Transflo Cushion deal is its third bolt-on acquisition since private equity firm NorthEdge Capital backed a management buyout in April 2016.
Direct Healthcare will assume all sales of the product following the transaction.
Ben Bradley said: “The Transflo Cushion is an extremely popular and proven product which has significant potential for growth.
“Its sale will enable the Transflo brand to achieve its full potential and allow Karomed to focus on its other products.
“I’m certain that the Transflo brand will go from strength to strength globally under the ownership of Direct Healthcare.”
Karomed managing director Emma Teasdale said: “We have been extremely proud of the development and popularity of the Transflo Cushion within the UK market.
“Direct Healthcare can now take this a step further.”
Graham Ewart, chief executive of Direct Healthcare, said: “The acquisition of the Transflo Cushion range enables DHG to offer Transflo customers an enhanced provision of service and product quality through our ISO 13485 accredited business management system.
“By increasing our product offering we ensure that we are providing innovative, market-leading pressure care management that makes a real difference to our healthcare professionals and the patients they provide care for.
“DHG’s global network will allow the Transflo Cushion range to be offered across Europe and Asia-Pacific for the first time, providing a strongly regarded, high-risk preventative product worldwide.
“This represents our continued intent to deliver pressure care solutions that provide value and benefit to our healthcare providers.”
Andrew Skinner, investment manager at NorthEdge Capital, said: “The team at DHG has continued to grow the business both organically and through the acquisition of specialist products and brands.
“This latest deal adds to the group’s diverse portfolio and supports further its growth in the healthcare market.
“The Transflo Cushion is highly regarded in the market, so we are pleased to welcome the product to the group and support DHG’s focus on providing outstanding patient care solutions.”
If you are thinking about an MBO, business disposal, or an acquisition please contact us at firstname.lastname@example.org